539 related articles for article (PubMed ID: 30223557)
1. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
Stylianou E
Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
[TBL] [Abstract][Full Text] [Related]
3. Proteomic insights on the metabolism in inflammatory bowel disease.
Pisani LF; Moriggi M; Gelfi C; Vecchi M; Pastorelli L
World J Gastroenterol; 2020 Feb; 26(7):696-705. PubMed ID: 32116417
[TBL] [Abstract][Full Text] [Related]
4. Metabolome and inflammasome in inflammatory bowel disease.
Nanau RM; Neuman MG
Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
[TBL] [Abstract][Full Text] [Related]
5. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
6. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.
Gisbert JP; Chaparro M
J Crohns Colitis; 2019 Mar; 13(3):374-384. PubMed ID: 30307487
[TBL] [Abstract][Full Text] [Related]
7. Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease - a review.
Cecerska-Heryć E; Ronkowski B; Heryć R; Serwin N; Grygorcewicz B; Roszak M; Galant K; Dołęgowska B
Proteomics Clin Appl; 2023 Jan; 17(1):e2200003. PubMed ID: 36043901
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.
Palmieri O; Mazza T; Castellana S; Panza A; Latiano T; Corritore G; Andriulli A; Latiano A
OMICS; 2016 Dec; 20(12):692-698. PubMed ID: 27930092
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
Bennike T; Birkelund S; Stensballe A; Andersen V
World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic biomarkers in inflammatory bowel disease].
Kanmura S; Sakiyama T; Uto H; Tsubouchi H
Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
[TBL] [Abstract][Full Text] [Related]
11. Challenges in IBD Research: Precision Medicine.
Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
[TBL] [Abstract][Full Text] [Related]
12. New proteomic approaches for biomarker discovery in inflammatory bowel disease.
Roda G; Caponi A; Benevento M; Nanni P; Mezzanotte L; Belluzzi A; Mayer L; Roda A
Inflamm Bowel Dis; 2010 Jul; 16(7):1239-46. PubMed ID: 20127998
[TBL] [Abstract][Full Text] [Related]
13. Personalized medicine in the treatment of inflammatory bowel diseases.
Parfenov AI; Knyazev OV; Kagramanova AV; Fadeeva NA
Ter Arkh; 2018 Feb; 90(2):4-11. PubMed ID: 30701765
[TBL] [Abstract][Full Text] [Related]
14. Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex.
Brooks J; Watson A; Korcsmaros T
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):101-109. PubMed ID: 28373027
[TBL] [Abstract][Full Text] [Related]
15. Integrating omics: the future of IBD?
Fiocchi C
Dig Dis; 2014; 32 Suppl 1():96-102. PubMed ID: 25531360
[TBL] [Abstract][Full Text] [Related]
16. Proteomics and metabolomics in inflammatory bowel disease.
Yau Y; Leong RW; Zeng M; Wasinger VC
J Gastroenterol Hepatol; 2013 Jul; 28(7):1076-86. PubMed ID: 23489082
[TBL] [Abstract][Full Text] [Related]
17. Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
Baldan-Martin M; Chaparro M; Gisbert JP
Inflamm Bowel Dis; 2021 Jul; 27(8):1184-1200. PubMed ID: 33529308
[TBL] [Abstract][Full Text] [Related]
18. Precision Medicine in Pediatric Inflammatory Bowel Disease.
Spencer EA; Dubinsky MC
Pediatr Clin North Am; 2021 Dec; 68(6):1171-1190. PubMed ID: 34736583
[TBL] [Abstract][Full Text] [Related]
19. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
[TBL] [Abstract][Full Text] [Related]
20. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.
Kumar M; Garand M; Al Khodor S
J Transl Med; 2019 Dec; 17(1):419. PubMed ID: 31836022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
